Sarepta Therapeutics (SRPT) Q4 2023 Earnings Call Transcript
The Motley Fool
FEBRUARY 28, 2024
Before we get to the results, I just wanted to flag that beginning in the fourth quarter of 2023, amortization of in-licensed rights and income tax expense or benefit are no longer excluded from non-GAAP results. And I'm sure there will be whitepapers and discussions among thought leaders on that topic.
100 
Let's personalize your content